[Morphological study of actinomycin D (dactinomycin)].
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D056486:Chemical and Drug Induced Liver Injury; D003609:Dactinomycin / Q000008:administration & dosage / Q000633:toxicity*; D003864:Depression, Chemical; D004798:Enzymes / Q000032:analysis; D006410:Hematopoiesis / Q000187:drug effects; D006651:Histocytochemistry; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008099:Liver / Q000032:analysis / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D008168:Lung / Q000473:pathology; D051379:Mice; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D012313:RNA / Q000037:antagonists & inhibitors; D011817:Rabbits; D013154:Spleen / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D013158:Splenic Diseases / Q000139:chemically induced; D013927:Thrombosis / Q000139:chemically induced; D013997:Time Factors
D004798:Enzymes; D003609:Dactinomycin; D012313:RNA
Morfologicheskoe izuchenie aktinomitsina D (daktinomitsina)